Circulating tumor cell as a diagnostic marker in primary lung cancer

Clinical Cancer Research

Volumn 15, Issue 22, 2009, Pages 6980-6986

  Tanaka, Fumihiro ^a   Yoneda, Kazue ^a   Kondo, Nobuyuki ^a   Hashimoto, Masaki ^a   Takuwa, Teruhisa ^a   Matsumoto, Seiji ^a   Okumura, Yoshitomo ^a   Rahman, Shakibur ^a   Tsubota, Noriaki ^a   Tsujimura, Tohru ^a   Kuribayashi, Kozo ^a   Fukuoka, Kazuya ^a   Nakano, Takashi ^a   Hasegawa, Seiki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; DISTANT METASTASIS; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORACOTOMY; TUMOR CELL; TUMOR GROWTH;

ANTIGENS, NEOPLASM; AREA UNDER CURVE; AUTOMATION; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 72549116858     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1095     Document Type: Article

References (19)

1. Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV. Diagnosis and management of lung cancer: evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:277-89s.
2. Alix-Panabières C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 2008;14:5013-5021
3. Alland WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-6904
4. Riethdort S, Fritsche H, Muller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch System. Clin Cancer Res 2007;13:920-928 (Pubitemid 46340368)
5. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791 (Pubitemid 39095313)
6. Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005;23:1420-1430
7. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-3221
8. Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008;19:935-938
9. de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008;14:6302-6309
10. Naoe M, Ogawa Y, Morita J, et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch system. Cancer 2007;109:1439-1445
11. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008;15:3092-3100
12. Okumura Y, Tanaka F, Yoneda K, et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 2009;87:1669-1675
13. Okada M, Nishio W, Sakamoto T, et al. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung cancer. Ann Thorac Surg 2004;78:1001-1010
14. Matsuguma H, Nakahara R, Igarashi S, et al. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg 2008;135:44-49
15. Hanley JA, McNeil BJ. The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. The American Thoracic Society and The European Respiratory Society. Pretereatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997;156:320-322
17. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008;83:584-594
18. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007;450:1235-1239
19. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating tumor cells. N Engl J Med 2008;359:366-377